Lysosomal storage disorders: The cellular impact of lysosomal dysfunction

Journal of Cell Biology

Volumn 199, Issue 5, 2012, Pages 723-734

  Platt, Frances M ^a   Boland, Barry ^b   van der Spoel, Aarnoud C ^c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MIGLUSTAT;

ARTICLE; ASPARTYLGLYCOSAMINURIA; AUTOPHAGY; CELL FUNCTION; CELL MEMBRANE; CELL ORGANELLE; CYSTINOSIS; DANON DISEASE; ENDOPLASMIC RETICULUM; ENZYME REPLACEMENT; FABRY DISEASE; GAUCHER DISEASE; GENE MUTATION; GLOBOID CELL LEUKODYSTROPHY; GLYCOGEN STORAGE DISEASE TYPE 2; GM1 GANGLIOSIDOSIS; HOMEOSTASIS; HUMAN; LYSOSOME; LYSOSOME STORAGE DISEASE; MALE; METACHROMATIC LEUKODYSTROPHY; MICROAUTOPHAGY; MUCOLIPIDOSIS; MUCOLIPIDOSIS TYPE 2; MUCOLIPIDOSIS TYPE 3; MUCOPOLYSACCHARIDOSIS; MULTIPLE SULFATASE DEFICIENCY; NIEMANN PICK DISEASE; NONHUMAN; PEROXISOME; PHENOTYPE; PRIORITY JOURNAL; SIALIC ACID STORAGE DISEASE; ANIMAL; BIOLOGICAL MODEL; CYTOLOGY; GENETICS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW;

ANIMALS; CELL BIOLOGY; HUMANS; LYSOSOMAL STORAGE DISEASES; LYSOSOMES; MODELS, BIOLOGICAL; PHENOTYPE;

EID: 84871960929     PISSN: 00219525     EISSN: 15408140     Source Type: Journal    
DOI: 10.1083/jcb.201208152     Document Type: Article

References (140)

1. Angelini, C., and C. Semplicini. 2012. Enzyme replacement therapy for Pompe disease. Curr. Neurol. Neurosci. Rep. 12:70-75. http://dx.doi.org/10 .1007/s11910-011-0236-5
2. Aqul, A., B. Liu, C.M. Ramirez, A.A. Pieper, S.J. Estill, D.K. Burns, B. Liu, J.J. Repa, S.D. Turley, and J.M. Dietschy. 2011. Unesterified cholesterol accumulation in late endosomes/lysosomes causes neurodegeneration and is prevented by driving cholesterol export from this compartment. J. Neurosci. 31:9404-9413. http://dx.doi.org/10.1523/JNEUROSCI.1317-11.2011
3. Balch, W.E., R.I. Morimoto, A. Dillin, and J.W. Kelly. 2008. Adapting proteostasis for disease intervention. Science. 319:916-919. http://dx.doi.org/10.1126/science.1141448
4. Ballabio, A. 2009. Disease pathogenesis explained by basic science: lysosomal storage diseases as autophagocytic disorders. Int. J. Clin. Pharmacol. Ther. 47(Suppl 1):S34-S38.
5. Ballabio, A., and V. Gieselmann. 2009. Lysosomal disorders: from storage to cellular damage. Biochim. Biophys. Acta. 1793:684-696. http://dx.doi.org/10.1016/j.bbamcr.2008.12.001
6. Bampton, E.T., C.G. Goemans, D. Niranjan, N. Mizushima, and A.M. Tolkovsky. 2005. The dynamics of autophagy visualized in live cells: from autophagosome formation to fusion with endo/lysosomes. Autophagy. 1:23-36. http://dx.doi.org/10.4161/auto.1.1.1495
7. Bellettato, C.M., and M. Scarpa. 2010. Pathophysiology of neuropathic lysosomal storage disorders. J. Inherit. Metab. Dis. 33:347-362. http://dx.doi.org/10.1007/s10545-010-9075-9
8. Boland, B., D.A. Smith, D. Mooney, S.S. Jung, D.M. Walsh, and F.M. Platt. 2010. Macroautophagy is not directly involved in the metabolism of amyloid precursor protein. J. Biol. Chem. 285:37415-37426. http://dx.doi.org/10.1074/jbc.M110.186411
9. Brady, R.O. 2006a. Emerging strategies for the treatment of hereditary metabolic storage disorders. Rejuvenation Res. 9:237-244. http://dx.doi.org/10.1089/rej.2006.9.237
10. Brady, R.O. 2006b. Enzyme replacement for lysosomal diseases. Annu. Rev. Med. 57:283-296. http://dx.doi.org/10.1146/annurev.med.57.110104.115650
11. Brady, R.O. 2010. Benefits from unearthing "a biochemical Rosetta Stone". J. Biol. Chem. 285:41216-41221. http://dx.doi.org/10.1074/jbc.X110.197954
12. Bright, N.A., B.J. Reaves, B.M. Mullock, and J.P. Luzio. 1997. Dense core lysosomes can fuse with late endosomes and are re-formed from the resultant hybrid organelles. J. Cell Sci. 110:2027-2040.
13. Bright, N.A., M.J. Gratian, and J.P. Luzio. 2005. Endocytic delivery to lysosomes mediated by concurrent fusion and kissing events in living cells. Curr. Biol. 15:360-365. http://dx.doi.org/10.1016/j.cub.2005.01.049
14. Brooks, D.A., V.J. Muller, and J.J. Hopwood. 2006. Stop-codon read-through for patients affected by a lysosomal storage disorder. Trends Mol. Med. 12:367-373. http://dx.doi.org/10.1016/j.molmed.2006.06.001
15. Burton, B.K. 1998. Inborn errors of metabolism in infancy: a guide to diagnosis. Pediatrics. 102:E69. http://dx.doi.org/10.1542/peds.102.6.e69
16. Cao, Y., J.A. Espinola, E. Fossale, A.C. Massey, A.M. Cuervo, M.E. MacDonald, and S.L. Cotman. 2006. Autophagy is disrupted in a knockin mouse model of juvenile neuronal ceroid lipofuscinosis. J. Biol. Chem. 281:20483-20493. http://dx.doi.org/10.1074/jbc.M602180200
17. Charrow, J. 2009. Enzyme replacement therapy for Gaucher disease. Expert Opin. Biol. Ther. 9:121-131. http://dx.doi.org/10.1517/14712590802573395
18. Chen, C.S., M.C. Patterson, C.L. Wheatley, J.F. O'Brien, and R.E. Pagano. 1999. Broad screening test for sphingolipid-storage diseases. Lancet. 354:901-905. http://dx.doi.org/10.1016/S0140-6736(98)10034-X
19. Chen, F.W., C. Li, and Y.A. Ioannou. 2010. Cyclodextrin induces calciumdependent lysosomal exocytosis. PLoS ONE. 5:e15054. http://dx.doi.org/10.1371/journal.pone.0015054
20. Churchill, G.C., Y. Okada, J.M. Thomas, A.A. Genazzani, S. Patel, and A. Galione. 2002. NAADP mobilizes Ca(2+) from reserve granules, lysosome-related organelles, in sea urchin eggs. Cell. 111:703-708. http://dx.doi.org/10.1016/S0092-8674(02)01082-6
21. Coen, K., R.S. Flannagan, S. Baron, L.R. Carraro-Lacroix, D. Wang, W. Vermeire, C. Michiels, S. Munck, V. Baert, S. Sugita, et al. 2012. Lysosomal calcium homeostasis defects, not proton pump defects, cause endo-lysosomal dysfunction in PSEN-deficient cells. J. Cell Biol. 198: 23-35. http://dx.doi.org/10.1083/jcb.201201076
22. Cox, T.M. 2010. Eliglustat tartrate, an orally active glucocerebroside synthase inhibitor for the potential treatment of Gaucher disease and other lysosomal storage diseases. Curr. Opin. Investig. Drugs. 11:1169-1181.
23. Cox, T.M., and M.B. Cachón-González. 2012. The cellular pathology of lysosomal diseases. J. Pathol. 226:241-254. http://dx.doi.org/10.1002/path.3021
24. Cuervo, A.M., and J.F. Dice. 2000. Regulation of lamp2a levels in the lysosomal membrane. Traffic. 1:570-583. http://dx.doi.org/10.1034/j.1600-0854.2000.010707.x
25. Davidson, C.D., N.F. Ali, M.C. Micsenyi, G. Stephney, S. Renault, K. Dobrenis, D.S. Ory, M.T. Vanier, and S.U. Walkley. 2009. Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression. PLoS ONE. 4:e6951. http://dx.doi.org/10.1371/journal.pone.0006951
26. Dice, J.F., S.R. Terlecky, H.L. Chiang, T.S. Olson, L.D. Isenman, S.R. Short-Russell, S. Freundlieb, and L.J. Terlecky. 1990. A selective pathway for degradation of cytosolic proteins by lysosomes. Semin. Cell Biol. 1:449-455.
27. Eden, E.R., I.J. White, A. Tsapara, and C.E. Futter. 2010. Membrane contacts between endosomes and ER provide sites for PTP1B-epidermal growth factor receptor interaction. Nat. Cell Biol. 12:267-272.
28. Elleder, M. 2006. Glucosylceramide transfer from lysosomes-the missing link in molecular pathology of glucosylceramidase deficiency: a hypothesis based on existing data. J. Inherit. Metab. Dis. 29:707-715. http://dx.doi.org/10.1007/s10545-006-0411-z
29. Eskelinen, E.L., and P. Saftig. 2009. Autophagy: a lysosomal degradation pathway with a central role in health and disease. Biochim. Biophys. Acta. 1793:664-673. http://dx.doi.org/10.1016/j.bbamcr.2008.07.014
30. Eskelinen, E.L., Y. Tanaka, and P. Saftig. 2003. At the acidic edge: emerging functions for lysosomal membrane proteins. Trends Cell Biol. 13:137-145. http://dx.doi.org/10.1016/S0962-8924(03)00005-9
31. Esselens, C., V. Oorschot, V. Baert, T. Raemaekers, K. Spittaels, L. Serneels, H. Zheng, P. Saftig, B. De Strooper, J. Klumperman, and W. Annaert. 2004. Presenilin 1 mediates the turnover of telencephalin in hippocampal neurons via an autophagic degradative pathway. J. Cell Biol. 166:1041-1054. http://dx.doi.org/10.1083/jcb.200406060
32. Ezaki, J., L.S. Wolfe, and E. Kominami. 1996. Specific delay in the degradation of mitochondrial ATP synthase subunit c in late infantile neuronal ceroid lipofuscinosis is derived from cellular proteolytic dysfunction rather than structural alteration of subunit c. J. Neurochem. 67:1677-1687. http://dx.doi.org/10.1046/j.1471-4159.1996.67041677.x
33. Fader, C.M., and M.I. Colombo. 2009. Autophagy and multivesicular bodies: two closely related partners. Cell Death Differ. 16:70-78. http://dx.doi.org/10.1038/cdd.2008.168
34. Fan, J.Q. 2008. A counterintuitive approach to treat enzyme deficiencies: use of enzyme inhibitors for restoring mutant enzyme activity. Biol. Chem. 389:1-11. http://dx.doi.org/10.1515/BC.2008.009
35. Farfel-Becker, T., E.B. Vitner, S.N. Pressey, R. Eilam, J.D. Cooper, and A.H. Futerman. 2011. Spatial and temporal correlation between neuron loss and neuroinflammation in a mouse model of neuronopathic Gaucher disease. Hum. Mol. Genet. 20:1375-1386. http://dx.doi.org/10.1093/hmg/ddr019
36. Fidzianska, A., E. Walczak, and M. Walski. 2007. Abnormal chaperone-mediated autophagy (CMA) in cardiomyocytes of a boy with Danon disease. Folia Neuropathol. 45:133-139.
37. Fraldi, A., F. Annunziata, A. Lombardi, H.J. Kaiser, D.L. Medina, C. Spampanato, A.O. Fedele, R. Polishchuk, N.C. Sorrentino, K. Simons, and A. Ballabio. 2010. Lysosomal fusion and SNARE function are impaired by cholesterol accumulation in lysosomal storage disorders. EMBO J. 29:3607-3620. http://dx.doi.org/10.1038/emboj.2010.237
38. Fuller, M., P.J. Meikle, and J.J. Hopwood. 2006. Epidemiology of lysosomal storage diseases: an overview. Oxford: Oxford PharmaGenesis; 2006. Chapter 2.
39. Futerman, A.H. 2010. Calcium homeostasis in lysosomal storage diseases. Int. J. Clin. Pharmacol. Ther. 48:S6-S7.
40. Futerman, A.H., and G. van Meer. 2004. The cell biology of lysosomal storage disorders. Nat. Rev. Mol. Cell Biol. 5:554-565. http://dx.doi.org/10.1038/nrm1423
41. García-Arencibia, M., W.E. Hochfeld, P.P. Toh, and D.C. Rubinsztein. 2010. Autophagy, a guardian against neurodegeneration. Semin. Cell Dev. Biol. 21:691-698. http://dx.doi.org/10.1016/j.semcdb.2010.02.008
42. Ghosh, P., N.M. Dahms, and S. Kornfeld. 2003. Mannose 6-phosphate receptors: new twists in the tale. Nat. Rev. Mol. Cell Biol. 4:202-212. http://dx.doi.org/10.1038/nrm1050
43. Ginzburg, L., and A.H. Futerman. 2005. Defective calcium homeostasis in the cerebellum in a mouse model of Niemann-Pick A disease. J. Neurochem. 95:1619-1628. http://dx.doi.org/10.1111/j.1471-4159.2005.03534.x
44. Goldman, S.D., and J.P. Krise. 2010. Niemann-Pick C1 functions independently of Niemann-Pick C2 in the initial stage of retrograde transport of membrane-impermeable lysosomal cargo. J. Biol. Chem. 285:4983-4994. http://dx.doi.org/10.1074/jbc.M109.037622
45. Green, D.R., L. Galluzzi, and G. Kroemer. 2011. Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science. 333:1109-1112. http://dx.doi.org/10.1126/science.1201940
46. Gritti, A. 2011. Gene therapy for lysosomal storage disorders. Expert Opin. Biol. Ther. 11:1153-1167. http://dx.doi.org/10.1517/14712598.2011.582036
47. Haq, E., M.A. Contreras, S. Giri, I. Singh, and A.K. Singh. 2006. Dysfunction of peroxisomes in twitcher mice brain: a possible mechanism of psychosine-induced disease. Biochem. Biophys. Res. Commun. 343:229-238. http://dx.doi.org/10.1016/j.bbrc.2006.02.131
48. Hers, H.G. 1963. alpha-Glucosidase deficiency in generalized glycogenstorage disease (Pompe's disease). Biochem. J. 86:11-16.
49. Jahreiss, L., F.M. Menzies, and D.C. Rubinsztein. 2008. The itinerary of autophagosomes: from peripheral formation to kiss-and-run fusion with lysosomes. Traffic. 9:574-587. http://dx.doi.org/10.1111/j.1600-0854.2008.00701.x
50. Jennings, J.J. Jr., J.H. Zhu, Y. Rbaibi, X. Luo, C.T. Chu, and K. Kiselyov. 2006. Mitochondrial aberrations in mucolipidosis Type IV. J. Biol. Chem. 281:39041-39050. http://dx.doi.org/10.1074/jbc.M607982200
51. Jesionek-Kupnicka, D., A. Majchrowska, J. Krawczyk, J. Wendorff, M. Barcikowska, S. Lukaszek, and P.P. Liberski. 1997. Krabbe disease: an ultrastructural study of globoid cells and reactive astrocytes at the brain and optic nerves. Folia Neuropathol. 35:155-162.
52. Kakkis, E.D. 2002. Enzyme replacement therapy for the mucopolysaccharide storage disorders. Expert Opin. Investig. Drugs. 11:675-685. http://dx.doi.org/10.1517/13543784.11.5.675
53. Kaufmann, A.M., S.D. Goldman, and J.P. Krise. 2009. A fluorescence resonance energy transfer-based approach for investigating late endosome-lysosome retrograde fusion events. Anal. Biochem. 386:91-97. http://dx.doi.org/10.1016/j.ab.2008.11.036
54. Kim, I., S. Rodriguez-Enriquez, and J.J. Lemasters. 2007. Selective degradation of mitochondria by mitophagy. Arch. Biochem. Biophys. 462:245-253. http://dx.doi.org/10.1016/j.abb.2007.03.034
55. Kirkegaard, T., A.G. Roth, N.H. Petersen, A.K. Mahalka, O.D. Olsen, I. Moilanen, A. Zylicz, J. Knudsen, K. Sandhoff, C. Arenz, et al. 2010. Hsp70 stabilizes lysosomes and reverts Niemann-Pick disease-associated lysosomal pathology. Nature. 463:549-553. http://dx.doi.org/10.1038/nature08710
56. Kitatani, K., J. Idkowiak-Baldys, and Y.A. Hannun. 2008. The sphingolipid salvage pathway in ceramide metabolism and signaling. Cell. Signal. 20:1010-1018. http://dx.doi.org/10.1016/j.cellsig.2007.12.006
57. Kitatani, K., K. Sheldon, V. Rajagopalan, V. Anelli, R.W. Jenkins, Y. Sun, G.A. Grabowski, L.M. Obeid, and Y.A. Hannun. 2009. Involvement of acid beta-glucosidase 1 in the salvage pathway of ceramide formation. J. Biol. Chem. 284:12972-12978. http://dx.doi.org/10.1074/jbc.M802790200
58. Klein, D., H. Büssow, S.N. Fewou, and V. Gieselmann. 2005. Exocytosis of storage material in a lysosomal disorder. Biochem. Biophys. Res. Commun. 327:663-667. http://dx.doi.org/10.1016/j.bbrc.2004.12.054
59. Koike, M., M. Shibata, S. Waguri, K. Yoshimura, I. Tanida, E. Kominami, T. Gotow, C. Peters, K. von Figura, N. Mizushima, et al. 2005. Participation of autophagy in storage of lysosomes in neurons from mouse models of neuronal ceroid-lipofuscinoses (Batten disease). Am. J. Pathol. 167:1713-1728. http://dx.doi.org/10.1016/S0002-9440(10)61253-9
60. Kopitz, J., A. Arnold, T. Meissner, and M. Cantz. 1993. Protein catabolism in fibroblasts cultured from patients with mucolipidosis II and other lysosomal disorders. Biochem. J. 295:577-580.
61. Krivit, W. 2002. Stem cell bone marrow transplantation in patients with metabolic storage diseases. Adv. Pediatr. 49:359-378.
62. Kuma, A., and N. Mizushima. 2010. Physiological role of autophagy as an intracellular recycling system: with an emphasis on nutrient metabolism. Semin. Cell Dev. Biol. 21:683-690. http://dx.doi.org/10.1016/j.semcdb.2010.03.002
63. Lachmann, R.H. 2006. Miglustat: substrate reduction therapy for glycosphingolipid lysosomal storage disorders. Drugs Today (Barc). 42:29-38. http:// dx.doi.org/10.1358/dot.2006.42.1.937457
64. Lamanna, W.C., R. Lawrence, S. Sarrazin, and J.D. Esko. 2011. Secondary storage of dermatan sulfate in Sanfilippo disease. J. Biol. Chem. 286:6955-6962. http://dx.doi.org/10.1074/jbc.M110.192062
65. Laplante, M., and D.M. Sabatini. 2012. mTOR signaling in growth control and disease. Cell. 149:274-293. http://dx.doi.org/10.1016/j.cell.2012.03.017
66. Lee, H., J.K. Lee, W.K. Min, J.H. Bae, X. He, E.H. Schuchman, J.S. Bae, and H.K. Jin. 2010. Bone marrow-derived mesenchymal stem cells prevent the loss of Niemann-Pick type C mouse Purkinje neurons by correcting sphingolipid metabolism and increasing sphingosine-1-phosphate. Stem Cells. 28:821-831. http://dx.doi.org/10.1002/stem.401
67. Lee, J.H., W.H. Yu, A. Kumar, S. Lee, P.S. Mohan, C.M. Peterhoff, D.M. Wolfe, M. Martinez-Vicente, A.C. Massey, G. Sovak, et al. 2010. Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell. 141:1146-1158. http://dx.doi.org/10.1016/j.cell.2010.05.008
68. Lloyd-Evans, E., and F.M. Platt. 2010. Lipids on trial: the search for the offending metabolite in Niemann-Pick type C disease. Traffic. 11:419-428. http://dx.doi.org/10.1111/j.1600-0854.2010.01032.x
69. Lloyd-Evans, E., A.J. Morgan, X. He, D.A. Smith, E. Elliot-Smith, D.J. Sillence, G.C. Churchill, E.H. Schuchman, A. Galione, and F.M. Platt. 2008. Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium. Nat. Med. 14:1247-1255. http://dx.doi.org/10.1038/nm.1876
70. Luzio, J.P., P.R. Pryor, and N.A. Bright. 2007. Lysosomes: fusion and function. Nat. Rev. Mol. Cell Biol. 8:622-632. http://dx.doi.org/10.1038/nrm2217
71. Medina, D.L., A. Fraldi, V. Bouche, F. Annunziata, G. Mansueto, C. Spampanato, C. Puri, A. Pignata, J.A. Martina, M. Sardiello, et al. 2011. Transcriptional activation of lysosomal exocytosis promotes cellular clearance. Dev. Cell. 21:421-430. http://dx.doi.org/10.1016/j.devcel.2011.07.016
72. Meikle, P.J., M.J. Fietz, and J.J. Hopwood. 2004. Diagnosis of lysosomal storage disorders: current techniques and future directions. Expert Rev. Mol. Diagn. 4:677-691. http://dx.doi.org/10.1586/14737159.4.5.677
73. Morgan, A.J., F.M. Platt, E. Lloyd-Evans, and A. Galione. 2011. Molecular mechanisms of endolysosomal Ca2+ signalling in health and disease. Biochem. J. 439:349-374. http://dx.doi.org/10.1042/BJ20110949
74. Mu, T.W., D.M. Fowler, and J.W. Kelly. 2008. Partial restoration of mutant enzyme homeostasis in three distinct lysosomal storage disease cell lines by altering calcium homeostasis. PLoS Biol. 6:e26. http://dx.doi.org/10.1371/journal.pbio.0060026
75. Mullock, B.M., N.A. Bright, C.W. Fearon, S.R. Gray, and J.P. Luzio. 1998. Fusion of lysosomes with late endosomes produces a hybrid organelle of intermediate density and is NSF dependent. J. Cell Biol. 140:591-601. http://dx.doi.org/10.1083/jcb.140.3.591
76. Nakahira, K., J.A. Haspel, V.A. Rathinam, S.J. Lee, T. Dolinay, H.C. Lam, J.A. Englert, M. Rabinovitch, M. Cernadas, H.P. Kim, et al. 2011. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat. Immunol. 12:222-230. http://dx.doi.org/10.1038/ni.1980
77. Neufeld, E.F. 2011. From serendipity to therapy. Annu. Rev. Biochem. 80:1-15. http://dx.doi.org/10.1146/annurev.biochem.031209.093756
78. Nixon, R.A., D.S. Yang, and J.H. Lee. 2008. Neurodegenerative lysosomal disorders: a continuum from development to late age. Autophagy. 4:590-599.
79. Okumiya, T., M.A. Kroos, L.V. Vliet, H. Takeuchi, A.T. Van der Ploeg, and A.J. Reuser. 2007. Chemical chaperones improve transport and enhance stability of mutant alpha-glucosidases in glycogen storage disease type II. Mol. Genet. Metab. 90:49-57. http://dx.doi.org/10.1016/j.ymgme.2006.09.010
80. Orsi, A., H.E. Polson, and S.A. Tooze. 2010. Membrane trafficking events that partake in autophagy. Curr. Opin. Cell Biol. 22:150-156. http://dx.doi.org/10.1016/j.ceb.2009.11.013
81. Pagano, R.E., V. Puri, M. Dominguez, and D.L. Marks. 2000. Membrane traffic in sphingolipid storage diseases. Traffic. 1:807-815. http://dx.doi.org/10.1034/j.1600-0854.2000.011101.x
82. Palmieri, M., S. Impey, H. Kang, A. di Ronza, C. Pelz, M. Sardiello, and A. Ballabio. 2011. Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways. Hum. Mol. Genet. 20:3852-3866. http://dx.doi.org/10.1093/hmg/ddr306
83. Patterson, M.C., D. Vecchio, H. Prady, L. Abel, and J.E. Wraith. 2007. Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study. Lancet Neurol. 6:765-772. http://dx.doi.org/10.1016/S1474-4422(07)70194-1
84. Peña-Llopis, S., S. Vega-Rubin-de-Celis, J.C. Schwartz, N.C. Wolff, T.A. Tran, L. Zou, X.J. Xie, D.R. Corey, and J. Brugarolas. 2011. Regulation of TFEB and V-ATPases by mTORC1. EMBO J. 30:3242-3258. http://dx.doi.org/10.1038/emboj.2011.257
85. Pisitkun, T., R.F. Shen, and M.A. Knepper. 2004. Identification and proteomic profiling of exosomes in human urine. Proc. Natl. Acad. Sci. USA. 101: 13368-13373. http://dx.doi.org/10.1073/pnas.0403453101
86. Platt, F.M., and T.D. Butters. 2004. Inhibition of substrate synthesis: a pharmacological approach for glycosphingolipid storage disease therapy. In Lysosomal Disorders of the Brain. F.M. Platt and S.U. Walkley, editors. Oxford University Press, Oxford. 381-408.
87. Platt, F.M., and M. Jeyakumar. 2008. Substrate reduction therapy. Acta Paediatr. Suppl. 97:88-93. http://dx.doi.org/10.1111/j.1651-2227.2008.00656.x
88. Platt, F.M., and S.U. Walkley. 2004. Lysosomal defects and storage. In Lysosomal Disorders of the Brain. F.M. Platt and S.U. Walkley, editors. Oxford University Press, Oxford. 32-49.
89. Platt, F.M., G.R. Neises, R.A. Dwek, and T.D. Butters. 1994. N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis. J. Biol. Chem. 269:8362-8365.
90. Pressey, S.N., D.A. Smith, A.M. Wong, F.M. Platt, and J.D. Cooper. 2012. Early glial activation, synaptic changes and axonal pathology in the thalamocortical system of Niemann-Pick type C1 mice. Neurobiol. Dis. 45:1086-1100. http://dx.doi.org/10.1016/j.nbd.2011.12.027
91. Prinetti, A., S. Prioni, E. Chiricozzi, E.H. Schuchman, V. Chigorno, and S. Sonnino. 2011. Secondary alterations of sphingolipid metabolism in lysosomal storage diseases. Neurochem. Res. 36:1654-1668. http://dx.doi.org/10.1007/s11064-010-0380-3
92. Pryor, P.R., B.M. Mullock, N.A. Bright, S.R. Gray, and J.P. Luzio. 2000. The role of intraorganellar Ca(2+) in late endosome-lysosome heterotypic fusion and in the reformation of lysosomes from hybrid organelles. J. Cell Biol. 149:1053-1062. http://dx.doi.org/10.1083/jcb.149.5.1053
93. Raben, N., L. Shea, V. Hill, and P. Plotz. 2009. Monitoring autophagy in lysosomal storage disorders. Methods Enzymol. 453:417-449. http://dx.doi.org/10.1016/S0076-6879(08)04021-4
94. Ravikumar, B., R. Duden, and D.C. Rubinsztein. 2002. Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. Hum. Mol. Genet. 11:1107-1117. http://dx.doi.org/10.1093/hmg/11.9.1107
95. Roczniak-Ferguson, A., C. Petit, S. Qian, and S. Ferguson. 2011. The interaction of MiT/TFE transcription factors with lysosomes contributes to regulation of lysosomal homeostasis. In Annual Meeting, The American Scociety for Cell Biology, Denver, CO.
96. Saftig, P., and J. Klumperman. 2009. Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function. Nat. Rev. Mol. Cell Biol. 10:623-635. http://dx.doi.org/10.1038/nrm2745
97. Sahu, R., S. Kaushik, C.C. Clement, E.S. Cannizzo, B. Scharf, A. Follenzi, I. Potolicchio, E. Nieves, A.M. Cuervo, and L. Santambrogio. 2011. Microautophagy of cytosolic proteins by late endosomes. Dev. Cell. 20:131-139. http://dx.doi.org/10.1016/j.devcel.2010.12.003
98. Sano, R., I. Annunziata, A. Patterson, S. Moshiach, E. Gomero, J. Opferman, M. Forte, and A. d'Azzo. 2009. GM1-ganglioside accumulation at the mitochondria-associated ER membranes links ER stress to Ca(2+)-dependent mitochondrial apoptosis. Mol. Cell. 36:500-511. http://dx.doi.org/10.1016/j.molcel.2009.10.021
99. Sardiello, M., M. Palmieri, A. di Ronza, D.L. Medina, M. Valenza, V.A. Gennarino, C. Di Malta, F. Donaudy, V. Embrione, R.S. Polishchuk, et al. 2009. A gene network regulating lysosomal biogenesis and function. Science. 325:473-477.
100. Schedin, S., P.J. Sindelar, P. Pentchev, U. Brunk, and G. Dallner. 1997. Peroxisomal impairment in Niemann-Pick type C disease. J. Biol. Chem. 272:6245-6251. http://dx.doi.org/10.1074/jbc.272.10.6245
101. Schiffmann, R., and R.O. Brady. 2006. Development of enzyme replacement therapy for Fabry disease. In Fabry Disease: Perspectives from 5 Years of FOS. A. Mehta, M. Beck, and G. Sunder-Plassmann, editors, Oxford.
102. Schmid, J.A., L. Mach, E. Paschke, and J. Glössl. 1999. Accumulation of sialic acid in endocytic compartments interferes with the formation of mature lysosomes. Impaired proteolytic processing of cathepsin B in fibroblasts of patients with lysosomal sialic acid storage disease. J. Biol. Chem. 274:19063-19071. http://dx.doi.org/10.1074/jbc.274.27.19063
103. Schröder, B.A., C. Wrocklage, A. Hasilik, and P. Saftig. 2010. The proteome of lysosomes. Proteomics. 10:4053-4076. http://dx.doi.org/10.1002/pmic.201000196
104. Schwarzmann, G., and K. Sandhoff. 1990. Metabolism and intracellular transport of glycosphingolipids. Biochemistry. 29:10865-10871. http://dx.doi.org/10.1021/bi00501a001
105. Settembre, C., A. Fraldi, L. Jahreiss, C. Spampanato, C. Venturi, D. Medina, R. de Pablo, C. Tacchetti, D.C. Rubinsztein, and A. Ballabio. 2008. A block of autophagy in lysosomal storage disorders. Hum. Mol. Genet. 17:119-129. http://dx.doi.org/10.1093/hmg/ddm289
106. Shapiro, B.E., E.L. Logigian, E.H. Kolodny, and G.M. Pastores. 2008. Late-onset Tay-Sachs disease: the spectrum of peripheral neuropathy in 30 affected patients. Muscle Nerve. 38:1012-1015. http://dx.doi.org/10.1002/mus.21061
107. Simons, M., and G. Raposo. 2009. Exosomes-vesicular carriers for intercellular communication. Curr. Opin. Cell Biol. 21:575-581. http://dx.doi.org/10.1016/j.ceb.2009.03.007
108. Singh, R., and A.M. Cuervo. 2011. Autophagy in the cellular energetic balance. Cell Metab. 13:495-504. http://dx.doi.org/10.1016/j.cmet.2011.04.004
109. Spada, M., S. Pagliardini, M. Yasuda, T. Tukel, G. Thiagarajan, H. Sakuraba, A.Ponzone, and R.J. Desnick. 2006. High incidence of later-onset fabry disease revealed by newborn screening. Am. J. Hum. Genet. 79:31-40. http://dx.doi.org/10.1086/504601
110. Strauss, K., C. Goebel, H. Runz, W. Möbius, S. Weiss, I. Feussner, M. Simons, and A. Schneider. 2010. Exosome secretion ameliorates lysosomal storage of cholesterol in Niemann-Pick type C disease. J. Biol. Chem. 285:26279-26288. http://dx.doi.org/10.1074/jbc.M110.134775
111. Suzuki, K., E. Iseki, T. Togo, A. Yamaguchi, O. Katsuse, K. Katsuyama, S. Kanzaki, K. Shiozaki, C. Kawanishi, S. Yamashita, et al. 2007. Neuronal and glial accumulation of alpha-and beta-synucleins in human lipidoses. Acta Neuropathol. 114:481-489. http://dx.doi.org/10.1007/s00401-007-0264-z
112. Takamura, A., K. Higaki, K. Kajimaki, S. Otsuka, H. Ninomiya, J. Matsuda, K. Ohno, Y. Suzuki, and E. Nanba. 2008. Enhanced autophagy and mitochondrial aberrations in murine G(M1)-gangliosidosis. Biochem. Biophys. Res. Commun. 367:616-622. http://dx.doi.org/10.1016/j.bbrc.2007.12.187
113. Takikita, S., R. Myerowitz, C. Schreiner, R. Baum, N. Raben, and P.H. Plotz. 2009. The values and limits of an in vitro model of Pompe disease: the best laid schemes o' mice an' men Autophagy. 5:729-731. http://dx.doi.org/10.4161/auto.5.5.8525
114. Terman, A., T. Kurz, M. Navratil, E.A. Arriaga, and U.T. Brunk. 2010. Mitochondrial turnover and aging of long-lived postmitotic cells: the mitochondrial-lysosomal axis theory of aging. Antioxid. Redox Signal. 12:503-535. http://dx.doi.org/10.1089/ars.2009.2598
115. Tessitore, A., M. del P Martin, R. Sano, Y. Ma, L. Mann, A. Ingrassia, E.D. Laywell, D.A. Steindler, L.M. Hendershot, and A. d'Azzo. 2004. GM1-ganglioside-mediated activation of the unfolded protein response causes neuronal death in a neurodegenerative gangliosidosis. Mol. Cell. 15:753-766. http://dx.doi.org/10.1016/j.molcel.2004.08.029
116. Tessitore, A., M. Pirozzi, and A. Auricchio. 2009. Abnormal autophagy, ubiquitination, inflammation and apoptosis are dependent upon lysosomal storage and are useful biomarkers of mucopolysaccharidosis VI. Pathogenetics. 2:4. http://dx.doi.org/10.1186/1755-8417-2-4
117. Tettamanti, G. 2004. Ganglioside/glycosphingolipid turnover: new concepts. Glycoconj. J. 20:301-317. http://dx.doi.org/10.1023/B:GLYC.0000033627.02765.cc
118. Tjelle, T.E., A. Brech, L.K. Juvet, G. Griffiths, and T. Berg. 1996. Isolation and characterization of early endosomes, late endosomes and terminal lysosomes: their role in protein degradation. J. Cell Sci. 109:2905-2914.
119. Tomanin, R., A. Zanetti, E. Zaccariotto, F. D'Avanzo, C.M. Bellettato, and M. Scarpa. 2012. Gene therapy approaches for lysosomal storage disorders, a good model for the treatment of mendelian diseases. Acta Paediatr. 101:692-701. http://dx.doi.org/10.1111/j.1651-2227.2012.02674.x
120. Toulmay, A., and W.A. Prinz. 2011. Lipid transfer and signaling at organelle contact sites: the tip of the iceberg. Curr. Opin. Cell Biol. 23:458-463. http://dx.doi.org/10.1016/j.ceb.2011.04.006
121. Valle, D., A.L. Beaudet, B. Vogelstein, K.W. Kinzler, S.E. Antonarakis, and A. Ballabio. 2012. The Online Metabolic and Molecular Bases of Inherited Diseases: http://www.ommbid.com/. Accessed Aug 7, 2012.
122. Venugopal, B., N.T. Mesires, J.C. Kennedy, C. Curcio-Morelli, J.M. Laplante, J.F. Dice, and S.A. Slaugenhaupt. 2009. Chaperone-mediated autophagy is defective in mucolipidosis type IV. J. Cell. Physiol. 219:344-353. http://dx.doi.org/10.1002/jcp.21676
123. Verity, C., A.M. Winstone, L. Stellitano, R. Will, and A. Nicoll. 2010. The epidemiology of progressive intellectual and neurological deterioration in childhood. Arch. Dis. Child. 95:361-364. http://dx.doi.org/10.1136/adc.2009.173419
124. Vitner, E.B., F.M. Platt, and A.H. Futerman. 2010. Common and uncommon pathogenic cascades in lysosomal storage diseases. J. Biol. Chem. 285:20423-20427. http://dx.doi.org/10.1074/jbc.R110.134452
125. Vitry, S., J. Bruyère, M. Hocquemiller, S. Bigou, J. Ausseil, M.A. Colle, M.C. Prévost, and J.M. Heard. 2010. Storage vesicles in neurons are related to Golgi complex alterations in mucopolysaccharidosis IIIB. Am. J. Pathol. 177:2984-2999. http://dx.doi.org/10.2353/ajpath.2010.100447
126. Walkley, S.U. 2007. Pathogenic mechanisms in lysosomal disease: a reappraisal of the role of the lysosome. Acta Paediatr. Suppl. 96:26-32. http://dx.doi.org/10.1111/j.1651-2227.2007.00202.x
127. Walkley, S.U., and M.T. Vanier. 2009. Secondary lipid accumulation in lysosomal disease. Biochim. Biophys. Acta. 1793:726-736. http://dx.doi.org/10.1016/j.bbamcr.2008.11.014
128. Ward, S., P. O'Donnell, S. Fernandez, and C.H. Vite. 2010. 2-hydroxypropylbeta-cyclodextrin raises hearing threshold in normal cats and in cats with Niemann-Pick type C disease. Pediatr. Res. 68:52-56. http://dx.doi.org/10.1203/PDR.0b013e3181df4623
129. Wilson, C.A., D.D. Murphy, B.I. Giasson, B. Zhang, J.Q. Trojanowski, and V.M. Lee. 2004. Degradative organelles containing mislocalized alphaand beta-synuclein proliferate in presenilin-1 null neurons. J. Cell Biol. 165:335-346. http://dx.doi.org/10.1083/jcb.200403061
130. Winchester, B. 2004. Primary defects in lysosomal enzymes. In Lysosomal Disorders of the Brain. F.M. Platt and S.U. Walkley, editors. Oxford University Press, Oxford. 81-130.
131. Winslow, A.R., C.W. Chen, S. Corrochano, A. Acevedo-Arozena, D.E. Gordon, A.A. Peden, M. Lichtenberg, F.M. Menzies, B. Ravikumar, S. Imarisio, et al. 2010. α-Synuclein impairs macroautophagy: implications for Parkinson's disease. J. Cell Biol. 190:1023-1037. http://dx.doi.org/10.1083/jcb.201003122
132. Wong, C.O., R. Li, C. Montell, and K. Venkatachalam. 2012. Drosophila TRPML Is Required for TORC1 Activation. Curr. Biol. 22:1616-1621. http://dx.doi.org/10.1016/j.cub.2012.06.055
133. Wong, E., and A.M. Cuervo. 2010. Autophagy gone awry in neurodegenerative diseases. Nat. Neurosci. 13:805-811. http://dx.doi.org/10.1038/nn.2575 Wraith, J.E. 2001. Advances in the treatment of lysosomal storage disease. Dev. Med. Child Neurol. 43:639-646. http://dx.doi.org/10.1017/S0012162201001165
134. Wraith, J.E. 2001. Advances in the treatment of lysosomal storage disease. Dev. Med. Child Neurol. 43:639-646. http://dx.doi.org/10.1017/S0012162201001165
135. Wraith, J.E. 2002. Lysosomal disorders. Semin. Neonatol. 7:75-83. http://dx.doi.org/10.1053/siny.2001.0088
136. Wraith, J.E. 2004. Clinical aspects and diagnosis. In Lysosomal disorders of the brain. F.M. Platt and S.U. Walkley, editors. Oxford University Press, Oxford. 50-77.
137. Xu, J., Y. Dang, Y.R. Ren, and J.O. Liu. 2010. Cholesterol trafficking is required for mTOR activation in endothelial cells. Proc. Natl. Acad. Sci. USA. 107:4764-4769. http://dx.doi.org/10.1073/pnas.0910872107
138. Yu, L., C.K. McPhee, L. Zheng, G.A. Mardones, Y. Rong, J. Peng, N. Mi, Y. Zhao, Z. Liu, F. Wan, et al. 2010. Termination of autophagy and reformation of lysosomes regulated by mTOR. Nature. 465:942-946. http://dx.doi.org/10.1038/nature09076
139. Zhou, R., A.S. Yazdi, P. Menu, and J. Tschopp. 2011. A role for mitochondria in NLRP3 inflammasome activation. Nature. 469:221-225. http://dx.doi.org/10.1038/nature09663
140. Zoncu, R., L. Bar-Peled, A. Efeyan, S. Wang, Y. Sancak, and D.M. Sabatini. 2011. mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar H(+)-ATPase. Science. 334:678-683. http://dx.doi.org/10.1126/science.1207056